Invion Limited (ASX:IVXO)

Australia · Delayed Price · Currency is AUD · Option

0.0020

0.00 (0.00%)

At close: Jun 17, 2026

-92.00% (1Y)

Market Cap	7.97M -60.8%
Revenue (ttm)	n/a
Net Income	-8.81M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	154,476
Open	0.0020
Previous Close	0.0020
Day's Range	0.0020 - 0.0020
52-Week Range	0.0020 - 0.0400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2025

About Invion

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2000

Employees 4

Stock Exchange Australian Securities Exchange

Ticker Symbol IVXO

Full Company Profile